Stay updated on Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial
Sign up to get notified when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.

Latest updates to the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page's related topics now include 'Multiple myeloma' and 'MedlinePlus Genetics', and the page revision tag has been updated from v3.6.3 to v3.6.4.SummaryDifference0.2%

- Check15 days agoChange DetectedThe related topics section no longer lists 'Multiple myeloma' and 'MedlinePlus Genetics', removing those links from the page context.SummaryDifference0.2%

- Check22 days agoChange DetectedRelated topics on the page were expanded to include 'Multiple myeloma' and a link to 'MedlinePlus Genetics'. This addition enhances navigation by connecting the study page to broader disease and genetics information.SummaryDifference0.2%

- Check30 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.2. This represents a minor page version update and does not modify study data or the information presented to users.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, reflecting an internal site update.SummaryDifference0.1%

- Check51 days agoChange DetectedEnrollment status indicates no new participants are being sought, and new help sections were added alongside a formatting adjustment to the Intervention/Treatment label and a revision bump to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.